Intercept Pharmaceuticals Inc
US ˙ NASDAQ ˙ US45845P1084
DETTE SYMBOL ER IKKE LÆNGERE AKTIVT

SecurityICPT / Intercept Pharmaceuticals Inc
InstitutionJefferies Group LLC
Latest Disclosed Ownership0 shares
Latest Disclosed Value $ 0
Jefferies Group LLC ownership in ICPT / Intercept Pharmaceuticals Inc

On September 21, 2023 - Jefferies Group LLC filed a 13F-HR/A form disclosing ownership of 0 shares of Intercept Pharmaceuticals Inc (US:ICPT) valued at $0 USD as of September 30, 2022. The entity filed a previous 13F-HR on August 15, 2022 disclosing 3,084 shares of Intercept Pharmaceuticals Inc. This represents a change in shares of -100.00% during the quarter. The current value of the position is $0 USD.

Jefferies Group LLC has a history of taking positions in derivatives of the underlying security (ICPT) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD and put options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

ICPT / Intercept Pharmaceuticals Inc Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2023-09-21 2022-09-30 13F/A-1 INTERCEPT PHARMACEUTICALS IN COM 45845P108 0 -3,084 -100.00 0 -100.00
2022-11-14 2022-09-30 13F INTERCEPT PHARMACEUTICALS IN COM 45845P108 0 -3,084 0
2022-08-15 2022-06-30 13F INTERCEPT PHARMACEUTICALS IN COM 45845P108 3,084 3,084 6 0.0000
2023-09-21 2022-03-31 13F/A-1 INTERCEPT PHARMACEUTICALS IN COM 45845P108 0 -27,781 -100.00 0 -100.00
2022-05-16 2022-03-31 13F INTERCEPT PHARMACEUTICALS IN COM 45845P108 0 -27,781 0
2022-02-14 2021-12-31 13F INTERCEPT PHARMACEUTICALS IN COM 45845P108 27,781 27,781 199 0.0011
2023-09-21 2021-03-31 13F/A-1 INTERCEPT PHARMACEUTICALS IN COM 45845P108 0 -22,406 -100.00 0 -100.00
2021-05-14 2021-03-31 13F INTERCEPT PHARMACEUTICALS IN COM 45845P108 0 -22,406 0
2023-09-21 2020-12-31 13F/A-1 INTERCEPT PHARMACEUTICALS IN COM 45845P108 22,406 3,251 16.97 553 -30.35 0.0043
2021-02-16 2020-12-31 13F INTERCEPT PHARMACEUTICALS IN COM 45845P108 22,406 3,251 553 0.0050
2020-11-13 2020-09-30 13F INTERCEPT PHARMACEUTICALS IN COM 45845P108 19,155 14,833 343.20 794 283.57 0.0088
2020-11-02 2020-06-30 13F/A-1 INTERCEPT PHARMACEUTICALS IN COM 45845P108 4,322 1,019 30.85 207 -0.48 0.0024
2020-08-14 2020-06-30 13F INTERCEPT PHARMACEUTICALS IN COM 45845P108 4,322 1,019 207 2,781.6359
2020-05-15 2020-03-31 13F INTERCEPT PHARMACEUTICALS IN COM 45845P108 3,303 -25,955 -88.71 208 -94.26 0.0026
2020-02-13 2019-12-31 13F INTERCEPT PHARMACEUTICALS IN COM 45845P108 29,258 28,708 5,219.64 3,626 9,972.22 0.0281
2019-11-13 2019-09-30 13F INTERCEPT PHARMACEUTICALS IN COM 45845P108 550 -30,070 -98.20 36 -98.52 0.0003
2019-08-14 2019-06-30 13F INTERCEPT PHARMACEUTICALS IN COM 45845P108 30,620 29,211 2,073.17 2,436 1,441.77 0.0178
2019-05-15 2019-03-31 13F INTERCEPT PHARMACEUTICALS IN COM 45845P108 1,409 -1,286 -47.72 158 -41.91 0.0013
2019-02-14 2018-12-31 13F INTERCEPT PHARMACEUTICALS IN COM 45845P108 2,695 2,695 272 0.0022
2018-05-15 2018-03-31 13F INTERCEPT PHARMACEUTICALS IN COM 45845P108 0 -66,313 -100.00 0 -100.00
2018-02-14 2017-12-31 13F INTERCEPT PHARMACEUTICALS IN COM 45845P108 66,313 -192,446 -74.37 3,874 -74.20 0.0182
2017-11-14 2017-09-30 13F INTERCEPT PHARMACEUTICALS IN COM 45845P108 258,759 256,831 13,321.11 15,018 6,345.49 0.0991
2017-08-14 2017-06-30 13F INTERCEPT PHARMACEUTICALS IN COM 45845P108 1,928 1,928 233 0.0016
2017-05-15 2017-03-31 13F INTERCEPT PHARMACEUTICALS IN COM 45845P108 0 -543 -100.00 0 -100.00
2017-02-14 2016-12-31 13F/A-1 INTERCEPT PHARMACEUTICALS IN COM 45845P108 543 -12,755 -95.92 59 -97.30 0.0003
2017-02-14 2016-12-31 13F INTERCEPT PHARMACEUTICALS IN COM 45845P108 543 59
2016-11-14 2016-09-30 13F INTERCEPT PHARMACEUTICALS IN COM 45845P108 13,298 13,298 0.00 2,189 0.0113
2016-08-12 2016-06-30 13F INTERCEPT PHARMACEUTICALS IN COM 45845P108 0 -2,523 -100.00 0 -100.00
2016-05-11 2016-03-31 13F INTERCEPT PHARMACEUTICALS IN COM 45845P108 2,523 -69 -2.66 324 -16.28 0.0019
2016-02-12 2015-12-31 13F INTERCEPT PHARMACEUTICALS IN COM 45845P108 2,592 1,009 63.74 387 47.15 0.0022
2015-11-13 2015-09-30 13F INTERCEPT PHARMACEUTICALS IN COM 45845P108 1,583 1,579 39,475.00 263 26,200.00 0.0015
2015-08-18 2015-06-30 13F INTERCEPT PHARMACEUTICALS IN COM 45845P108 4 4 0.00 1 0.0000
2015-02-17 2014-12-31 13F INTERCEPT PHARMACEUTICALS IN COM 45845P108 0 -7,960 -100.00 0 -100.00
2014-11-17 2014-09-30 13F INTERCEPT PHARMACEUTICALS IN COM 45845P108 7,960 6,015 309.25 1,884 308.68 0.0129
2014-08-14 2014-06-30 13F INTERCEPT PHARMACEUTICALS IN COM 45845P108 1,945 1,945 461 0.0039
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2020-05-15 2020-03-31 13F INTERCEPT PHARMACEUTICALS IN COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2020-02-13 2019-12-31 13F INTERCEPT PHARMACEUTICALS IN COM Call 162,300 55.91 20,112 191.14 n/a n/a n/a
2019-11-13 2019-09-30 13F INTERCEPT PHARMACEUTICALS IN COM Call 104,100 6,908 n/a n/a n/a
2019-08-14 2019-06-30 13F INTERCEPT PHARMACEUTICALS IN COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2019-05-15 2019-03-31 13F INTERCEPT PHARMACEUTICALS IN COM Call 1,000 -94.85 112 -94.27 n/a n/a n/a
2019-02-14 2018-12-31 13F INTERCEPT PHARMACEUTICALS IN COM Call 19,400 1,955 n/a n/a n/a
2018-02-14 2017-12-31 13F INTERCEPT PHARMACEUTICALS IN COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2017-11-14 2017-09-30 13F INTERCEPT PHARMACEUTICALS IN COM Call 90,000 5,224 n/a n/a n/a
2017-05-15 2017-03-31 13F INTERCEPT PHARMACEUTICALS IN COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2017-02-14 2016-12-31 13F/A INTERCEPT PHARMACEUTICALS IN COM Call 4,000 0.00 435 -33.89 n/a n/a n/a
2017-02-14 2016-12-31 13F INTERCEPT PHARMACEUTICALS IN COM Call 4,000 435 n/a n/a n/a
2016-11-14 2016-09-30 13F INTERCEPT PHARMACEUTICALS IN COM Call 4,000 658 n/a n/a n/a
2016-08-12 2016-06-30 13F INTERCEPT PHARMACEUTICALS IN COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2016-05-11 2016-03-31 13F INTERCEPT PHARMACEUTICALS IN COM Call 38,100 4,895 n/a n/a n/a
2015-05-18 2015-03-31 13F INTERCEPT PHARMACEUTICALS IN COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2015-02-17 2014-12-31 13F INTERCEPT PHARMACEUTICALS IN COM Call 4,000 624 n/a n/a n/a
2014-11-17 2014-09-30 13F INTERCEPT PHARMACEUTICALS IN COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2014-08-14 2014-06-30 13F INTERCEPT PHARMACEUTICALS IN COM Call 10,000 2,366 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2023-09-21 2022-09-30 13F/A INTERCEPT PHARMACEUTICALS IN COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2022-11-14 2022-09-30 13F INTERCEPT PHARMACEUTICALS IN COM Put 0 0 n/a n/a n/a
2023-09-21 2022-06-30 13F/A INTERCEPT PHARMACEUTICALS IN COM Put 10,000 138 n/a n/a n/a
2022-08-15 2022-06-30 13F INTERCEPT PHARMACEUTICALS IN COM Put 10,000 138 n/a n/a n/a
2023-09-21 2022-03-31 13F/A INTERCEPT PHARMACEUTICALS IN COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2022-05-16 2022-03-31 13F INTERCEPT PHARMACEUTICALS IN COM Put 0 0 n/a n/a n/a
2023-09-21 2021-12-31 13F/A INTERCEPT PHARMACEUTICALS IN COM Put 56,500 0.00 920 9.65 n/a n/a n/a
2022-02-14 2021-12-31 13F INTERCEPT PHARMACEUTICALS IN COM Put 56,500 920 n/a n/a n/a
2021-12-17 2021-09-30 13F/A INTERCEPT PHARMACEUTICALS IN COM Put 56,500 839 n/a n/a n/a
2023-09-21 2021-09-30 13F/A INTERCEPT PHARMACEUTICALS IN COM Put 56,500 839 n/a n/a n/a
2021-11-15 2021-09-30 13F INTERCEPT PHARMACEUTICALS IN COM Put 56,500 839 n/a n/a n/a
2023-09-21 2021-03-31 13F/A INTERCEPT PHARMACEUTICALS IN COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2021-05-14 2021-03-31 13F INTERCEPT PHARMACEUTICALS IN COM Put 0 0 n/a n/a n/a
2023-09-21 2020-12-31 13F/A INTERCEPT PHARMACEUTICALS IN COM Put 23,000 -11.54 568 -47.31 n/a n/a n/a
2021-02-16 2020-12-31 13F INTERCEPT PHARMACEUTICALS IN COM Put 23,000 568 n/a n/a n/a
2020-11-13 2020-09-30 13F INTERCEPT PHARMACEUTICALS IN COM Put 26,000 0.00 1,078 -13.48 n/a n/a n/a
2020-11-02 2020-06-30 13F/A INTERCEPT PHARMACEUTICALS IN COM Put 26,000 0.00 1,246 -23.89 n/a n/a n/a
2020-08-14 2020-06-30 13F INTERCEPT PHARMACEUTICALS IN COM Put 26,000 1,246 n/a n/a n/a
2020-05-15 2020-03-31 13F INTERCEPT PHARMACEUTICALS IN COM Put 26,000 -13.62 1,637 -56.11 n/a n/a n/a
2020-02-13 2019-12-31 13F INTERCEPT PHARMACEUTICALS IN COM Put 30,100 -0.99 3,730 84.93 n/a n/a n/a
2019-11-13 2019-09-30 13F INTERCEPT PHARMACEUTICALS IN COM Put 30,400 -15.56 2,017 -29.60 n/a n/a n/a
2019-08-14 2019-06-30 13F INTERCEPT PHARMACEUTICALS IN COM Put 36,000 60.71 2,865 14.33 n/a n/a n/a
2019-05-15 2019-03-31 13F INTERCEPT PHARMACEUTICALS IN COM Put 22,400 220.00 2,506 254.96 n/a n/a n/a
2019-02-14 2018-12-31 13F INTERCEPT PHARMACEUTICALS IN COM Put 7,000 706 n/a n/a n/a
2018-05-15 2018-03-31 13F INTERCEPT PHARMACEUTICALS IN COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2018-02-14 2017-12-31 13F INTERCEPT PHARMACEUTICALS IN COM Put 67,300 115.71 3,932 117.12 n/a n/a n/a
2017-11-14 2017-09-30 13F INTERCEPT PHARMACEUTICALS IN COM Put 31,200 1,811 n/a n/a n/a
2017-05-15 2017-03-31 13F INTERCEPT PHARMACEUTICALS IN COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2017-02-14 2016-12-31 13F/A INTERCEPT PHARMACEUTICALS IN COM Put 500 54 n/a n/a n/a
2017-02-14 2016-12-31 13F INTERCEPT PHARMACEUTICALS IN COM Put 500 54 n/a n/a n/a
2015-05-18 2015-03-31 13F INTERCEPT PHARMACEUTICALS IN COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2015-02-17 2014-12-31 13F INTERCEPT PHARMACEUTICALS IN COM Put 20,500 2.50 3,198 -32.45 n/a n/a n/a
2014-11-17 2014-09-30 13F INTERCEPT PHARMACEUTICALS IN COM Put 20,000 100.00 4,734 100.08 n/a n/a n/a
2014-08-14 2014-06-30 13F INTERCEPT PHARMACEUTICALS IN COM Put 10,000 2,366 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.